Clinical studies at the Rostock/Greifswald site

If you would like to support our research by participating, you can find here an overview of all studies for which we are currently looking for subjects at the Rostock/Greifswald site.

You can refine your search using the filters for the target group or a specific diagnosis.

ARCA (Autosomal-Recessive Cerebellar Ataxias)
In this DZNE network research project (Autosomal Recessive Cerebellar Ataxia Registry, ARCA registry), modern methods are being used to search for new ataxia genes and biomarkers in autosomal recessive ataxias and early onset ataxias with onset before the age of 40.
Corona and cognition (The effects of restrictions caused by the coronavirus SARS-CoV-2 on cognitive health and dementia prevention)
This study examines the effects of social, emotional, and occupational changes due to SARS-Co-V2 coronavirus limitations on cognition and prevention of mental decline.
Costs of specialized dementia diagnostics using the example of the Memory Klinik of the University of Rostock
By analysing the total costs of specialised dementia diagnostics, it should be made possible to measure the resulting costs for the memory clinic, given a known patient volume, and thus provide a basis for estimating the diagnostic costs of dementia for society as a whole.
DANCER (Establishment of a Recruitment Pool of Potential Study Participants, of Realtives and a Control Group for DZNE Studies)
One focus of these studies is the identification of early, specific changes, for example in the blood, so that the diagnosis of a neurodegenerative disease such as dementia or Parkinson's can be made at a very early stage. This enables a better understanding of the diseases and supports the development of new forms of therapy.
DANCER-FTD (Recruitment of Realtives and a Control Group for the DESCRIBE-FTD Study)
In order for us to assess study outcomes of patients with neurological frontotemporal dementia (FTD), comparative studies with relatives of patients with FTD as well as interested individuals without a diagnosis of neurodegenerative disease are needed.
DANCER-PSP (Recruitment of Realtives and a Control Group for the DESCRIBE-PSP Study)
Comparative studies with relatives of patients with PSP and interested individuals without a diagnosis of neurodegenerative disease are needed to assess study outcomes of patients with progressive supranuclear palsy (PSP).
DCAAS (DZNE Cerebral Amyloid Angiopathy Study)
Cerebral amyloid angiopathy (CAA) is a disease of the vessels in the brain in which proteins, known as amyloid, are deposited in the walls of the vessels. There are initial indications of possible mechanisms and biomarkers that influence the course of the disease, but there are still many unanswered questions.
DELCODE (DZNE - Longitudinal Cognitive Impairment and Dementia study)
Early detection of Alzheimer's disease, if possible, before the onset of symptoms or at the first mild symptoms as a prerequisite for the development of therapies.
DESCRIBE (DZNE - Clinical Register Study of neurodegenerative Disorders)
The aim of the DESCRIBE study is to use the examination results obtained in the course of normal patient care together with findings from diagnostics on biomaterials, including genetic analysis, for scientific purposes.
DESCRIBE-FTD (DZNE - Clinical Registry Study on Frontotemporal Dementia (FTD))
The aim of the DESCRIBE-FTD study is to describe in detail the course of FTD in its various clinical manifestations. The aim is to gain a better understanding of the underlying pathology and to identify parameters that enable diagnosis and prediction of the course of the disease.
DESCRIBE-PSP (DZNE - Clinical Registry Study on Progressive Supranuclear Paresis (PSP))
The aim of the DESCRIBE-PSP study is to document the early and atypical course of PSP in order to enable improved diagnostic criteria and therapy studies in the early course of the disease.
Education for relatives "Living with dementia"
Training series for relatives: Positive effects in care by providing background knowledge and showing possibilities in the daily handling of people with dementia as well as suitable relief and care strategies so that people with dementia can be cared for longer in the home.
ENABLE (Patient- and care-related benefits of amyloid PET imaging)
The aim of the ENABLE trial is to test whether amyloid PET screening has the potential to improve the care of dementia patients in the German health care system and thus contribute to the preservation or slowed loss of everyday functions.
EPND Glossary Feedback Survey
The European Platform for Neurodegenerative Diseases (EPND) Glossary was established to provide the basis for a consistent, high-quality use of terminology for neurodegenerative diseases.
EQ-5D-ATAX (Psychometric properties of the EQ-5D in rare ataxia diseases)
Study on the suitability of the EQ-5D questionnaire as a suitable instrument to assess health-related quality of life in patients with rare ataxia disorders.
HSP-Net (Networking Project on Hereditary Spastic Paraplegia)
Spastic spinal paralysis (HSP) is a rare, often hereditary, slowly progressive disease characterized by a spastic gait disorder. The HSP project involves the establishment and conduct of a multicenter study of the natural longitudinal course of hereditary spastic spinal paralysis.
PROFA (Patient-reported, health economic and psychosocial outcomes in Friedreich Ataxia)
Investigation of the impact of Friedreich's ataxia on patient-related, health economic, and psychosocial outcomes using self-reported data collection via a patient-centered e-health app.
PROSA (A Low-burden High-frequency PROgnostic Digital Speech Biomarker to Improve Future Confirmatory ALS and FTD Trials)
Development and validation of a novel speech biomarker for the ALS-FTD disease spectrum based on speech measurements that can be collected repeatedly and remotely by telephone to assess three key symptom groups: Cognition (language, executive functions and memory), motor function and respiratory function.
Prospect-AD (Population-based screening over speech for clinical trials in Alzheimer’s Disease)
Subjective memory impairment (SCD) or mild cognitive impairment (MCI) may be associated with an increased risk of dementia later in life. Early preventive measures can potentially reduce the risk of dementia. This requires early detection of early signs of cognitive impairment.
REMINDer (Online study to evaluate the feasibility and effectiveness of a multimodal online exercise program for elderly adults)
The DZNE Dresden is investigating the feasibility and effectiveness of a six-week multimodal online program with music, movement and mindfulness exercises for people aged 60 - 80 years.
SPORTAX-NHS (Observational Study on Adult Onset Sporadic Ataxias)
The SPORTAX study aims to precisely characterize the two forms of the disease and to compare the courses of the disease. In addition, factors are to be identified that allow a more precise assignment of the disease at an early stage and that can influence the development of the disease.

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: